Project Grant R01GM144421

Award Date 9/24/22
Completion Date 7/31/25
Dollars Obligated $1.9M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Oak Ridge, TN 37831, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $306,860 to Mixedlcmedia LLC, a small disadvantaged business, to develop and evaluate a prototype ultra-low flow liquid chromatography platform based on their proprietary porous layer open-tubular (PLOT) and monolithic nanocolumn technologies. The goal is to create a commercialization-ready LC system that enables deep proteomic...
Partillion Bioscience Corp. was awarded a $659,037 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences to develop reagent products enabling high-throughput screening and selection of single cells based on secreted bio-products. Under the Biomedical Research and Research Training program (CFDA 93.859), Partillion plans to transition its lab-on-a-particle technology—highlighted as a 2020 SLAS Innovation Award winner—into the first reagent product...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $750,000 to Rowan University to develop a sensor-like liquid chromatography-mass spectrometry (LC-MS) platform for rapid, real-time monitoring of metabolites in biological systems. The key products and services to be delivered include: Creation of a high-throughput, miniaturized LC-MS system with improved analyte selectivity...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA program 93.859 Biomedical Research and Research Training provides $350,000 to Fluidispec LLC to develop a new microfluidic/nanofluidic sample preparation platform. The goal is to improve single-cell and low-input proteomics analysis by enabling efficient extraction of proteins from cells, removal of contaminants, and improved protein denaturation. This platform is expected to enhance...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $658,336 to Rarecyte, Inc. to develop the ORION2 instrument, a system that will enable highly multiplexed spatial profiling of tumor and tissue samples. The key products and services to be delivered under this 3-year award (June 2025 - May 2028) include: Developing an automated imaging system with adaptive controls to balance speed of data acquisition and image...
The National Science Foundation (NSF) Division of Molecular and Cellular Biosciences awarded a $590,000 Project Grant to the University of California Irvine (UC Irvine) on August 15, 2023 under the Biological Sciences program (CFDA 47.074). The goal of this 3-year research project is to develop novel strategies for real-time metabolite sensing and metabolite-induced enzyme localization that can contribute to fundamental cellular knowledge and improve the efficiency of synthetic biology...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of their Plasmonic Scattering Microscopy (PSM) technology. The PSM system aims to enable high-throughput, label-free quantification of membrane protein binding kinetics on single cells in their native cellular microenvironment. This represents a...
This $600,120 federal Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports the development of a groundbreaking microfluidic-based weighing instrument capable of measuring mass changes in live single cells with picogram accuracy and millisecond resolution. The Icahn School of Medicine at Mount Sinai, a prominent academic medical research institution, will lead this 4-year research project. The instrument will utilize small pipettes to...
The National Institute of General Medical Sciences (NIGMS) awarded a $333,048 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Imagen Bioworks Inc. in Houston, TX. The goal of this 1-year project is to develop a versatile 2-photon microscopy platform, dubbed 2P-SPOTLIGHT, to isolate individual cells from 3D tissue samples and 3D cell cultures based on their spatial and temporal properties. This will enable researchers to conduct downstream multi-omics...
This $330,076 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of a novel photothermal microscopy platform by Trestle Optics LLC, a small disadvantaged business located in Irvine, California. The goal of this project is to create an advanced optical imaging system that can non-destructively profile cellular metabolites, providing critical insights for...

DEVELOPMENT OF SINGLE CELL PRINTING-LIQUID VORTEX CAPTURE-MASS SPECTROMETRY FOR THE METABOLIC PROFILING OF SINGLE CELLS - PROJECT SUMMARY THE MECHANISMS UNDERPINNING HETEROGENEOUS METABOLIC RESPONSE BETWEEN INDIVIDUAL CELLS REMAIN POORLY UNDERSTOOD, THOUGH SUCH MECHANISMS HAVE RAMIFICATIONS ACROSS NEARLY ALL OF MEDICINE, E.G., DISEASE DETECTION, RESPONSE TO STRESS, TREATMENT, AND MORE. INTRACELLULAR SMALL MOLECULE METABOLITE, LIPID AND THERAPEUTIC CONCENTRATIONS ARE OFTEN INFERRED THROUGH PROTEIN EXPRESSION OR DIRECTLY MEASURED AS THE AVERAGE OF 1000'S OF CELLS AT ONCE, PROVIDING ONLY A POPULATION-LEVEL VIEW OF HETEROGENEOUS METABOLIC RESPONSE. THIS OBFUSCATES DIFFERENTIATION OF ANOMALOUS METABOLIC CELL PHENOTYPES AND SMALL MOLECULE ASSOCIATIONS OCCURRING WITHIN CELLS. CURRENTLY THERE EXISTS A GAP IN ANALYTICAL TECHNOLOGIES FOR THE MEASURE OF SMALL MOLECULES (

Posted 9/23/22, 12:00 AM